Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,490 | 860 | 740 |
| Other current assets | 80 | 0 | 0 |
| TOTAL | $1,570 | $860 | $740 |
| Non-Current Assets | |||
| PPE Net | N/A | 90 | 10 |
| Other Non-Current Assets | 70 | 195 | 150 |
| TOTAL | $70 | $285 | $160 |
| Total Assets | $1,760 | $1,170 | $930 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 230 | 290 | 220 |
| Accrued Expenses | 110 | 190 | 70 |
| Other current liabilities | 0 | 10 | 10 |
| TOTAL | $550 | $490 | $310 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 190 | 1,310 |
| TOTAL | $N/A | $190 | $1,310 |
| Total Liabilities | $550 | $680 | $1,620 |
| Shareholders' Equity | |||
| Common Shares | 10 | 10 | 10 |
| Retained earnings | -4,150 | -1,620 | -940 |
| Other shareholders' equity | -100 | 810 | 140 |
| TOTAL | $1,210 | $480 | $-690 |
| Total Liabilities And Equity | $1,760 | $1,160 | $930 |